Shalin Shah

But no, I mean, look, the opportunity kind of came across the desk and, you know,

I have, I have a research background in the investment world and continued to sort of dig and dig on this topic.

And there was just a massive dichotomy between the perception of testosterone and then what I was reading in terms of what it actually does.

Right.

So in, in that disconnect was, was frankly just too big to, to ignore.

Um,

it, it, again, to me, it didn't make any sense.

And, and I felt that there was an opportunity to do something about it.

Uh, especially considering, again, we're talking about a problem that is so big, you know, in the U S there's 25 million men that are testosterone deficient.

Um, you're talking about, you know, a hundred million plus globally.

Um, I mentioned there's probably 500 million people globally, both men and female that need testosterone.

So you have such a big problem.

And I looked at the solutions.

And historically, this was mainly, you know, this is mainly done by injection.

And we know that's a hard ask for a lot of people to do, especially on a regular basis, right?

And I'll share another reason why it doesn't, you know, that doesn't really work in a second.

But we went and pursued an oral option.

So we said, look, if we can make this into a pill that's safe and effective, think about how many people we can help.

And that really, you know, again, the combination of how misunderstood this was with how great a solution we could potentially bring to the market, couldn't ignore it.

Wow.